Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
01 juin 2024 10h00 HE
|
Genmab A/S
Media Release COPENHAGEN, Denmark, and MAINZ, Germany; June 1, 2024 Initial data from the ongoing Phase 2 trial showed a 12-month overall survival (OS) rate of 69% and median overall survival...
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
01 juin 2024 08h15 HE
|
Ultimovacs ASA
NON-REGULATORY PRESS RELEASE Oslo, June 1, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announces that...
NIO Inc. Provides May 2024 Delivery Update
01 juin 2024 05h30 HE
|
NIO Inc.
NIO delivered 20,544 vehicles in May 2024, increasing by 233.8% year-over-yearNIO delivered 66,217 vehicles year-to-date in 2024, increasing by 51.0% year-over-year Cumulative deliveries of NIO...
XPENG Announces Vehicle Delivery Results for May 2024
01 juin 2024 05h00 HE
|
XPeng Inc.
GUANGZHOU, China, June 01, 2024 (GLOBE NEWSWIRE) -- XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announced...
BIGBEN: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
01 juin 2024 02h00 HE
|
Bigben Interactive
Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social Article 223-16 du Règlement Général de l'Autorité des Marchés...
Mayfair Gold Announces that Certain Employees May Withdraw Notices of Termination under Change of Control to Continue Employment with the Company
31 mai 2024 18h00 HE
|
Mayfair Gold Corp.
MATHESON, Ontario, May 31, 2024 (GLOBE NEWSWIRE) -- Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) announces that it has received correspondence from all Terminating...
BOUSSARD & GAVAUDAN HOLDING LIMITED (GBP) : Transaction in Own Shares
31 mai 2024 13h04 HE
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
BOUSSARD & GAVAUDAN HOLDING LIMITED May 2024 TRANSACTION IN OWN SECURITIES ACTIVITY REPORT1 The Company announces that pursuant to the general authority granted by shareholders of the Company on...
BOUSSARD & GAVAUDAN HOLDING LIMITED (EUR) : Transaction in Own Shares
31 mai 2024 13h00 HE
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
BOUSSARD & GAVAUDAN HOLDING LIMITED May 2024 TRANSACTION IN OWN SECURITIES ACTIVITY REPORT1 The Company announces that pursuant to the general authority granted by shareholders of the Company on...
Banco Comercial Português, S.A. informa sobre Relatório e Contas 1T 2024
31 mai 2024 12h51 HE
|
Banco Comercial Portugues, S.A.
Banco Comercial Português, S.A. informa sobre Relatório e Contas 1T 2024
Anexo
RCBCP1T2024
...
Banco Comercial Português, S.A. informs on Q1 2024 Report & Accounts
31 mai 2024 12h51 HE
|
Banco Comercial Portugues, S.A.
Banco Comercial Português, S.A. informs on Q1 2024 Report & Accounts
Attachment
RABCPQ12024
...